Have a personal or library account? Click to login
Borders between integrative medicine and EBM: significance, potential for use and legal issues in European Union member states. Narrative review Cover

Borders between integrative medicine and EBM: significance, potential for use and legal issues in European Union member states. Narrative review

Open Access
|Jun 2022

References

  1. 1. WHO global report on traditional and complementary medicine 2019. Accessed September 8, 2021. https://www.who.int/publications/i/item/978924151536.
  2. 2. Complementary, Alternative, or Integrative Health: What’s In a Name? | NCCIH. Accessed September 27, 2021. https://www.nccih.nih.gov/health/complementary-alternative-or-integrative-health-whats-in-a-name.
  3. 3. Barry CA. The role of evidence in alternative medicine: Contrasting biomedical and anthropological approaches. Soc. Sci. Med. 2006; 62(11): 2646-2657.10.1016/j.socscimed.2005.11.02516376470
  4. 4. Wang CC, Geale SK. The power of story: Narrative inquiry as a methodology in nursing research. Int. J. Nurs. 2015, 2(2); 195-198.10.1016/j.ijnss.2015.04.014
  5. 5. Hegyi G, Petri RP, Sarsina PR, et al. Overview of Integrative Medicine Practices and Policies in NATO Participant Countries. Med. Acupunct. 2015; 27(5): 318.10.1089/acu.2014.1085462398726543517
  6. 6. Kwon JH, Lee SC, Lee MA, et al. Behaviors and attitudes toward the use of complementary and alternative medicine among Korean cancer patients. Cancer Res Treat. 2019; 51(3): 851-860.10.4143/crt.2019.137663922031208165
  7. 7. Eisele G, Roelcke U, Conen K, et al. Complementary and alternative medicine use by glioma patients in Switzerland. Neuro-Oncology Pract. 2019; 6(3): 237-244.10.1093/nop/npy035665632531386047
  8. 8. Johnson SB, Parson M, Dorff T, et al. Cancer Misinformation and Harmful Information on Facebook and Other Social Media: a Brief Report. J. Natl. Cancer Inst. 2021; 22:djab141. doi: 10.1093/jnci/djab141927577234291289
  9. 9. Garrett B, Murphy S, Jamal S, et al. Internet health scams-Developing a taxonomy and risk-of-deception assessment tool. Health Soc. Care. Community. 2019; 27(1): 226-240.10.1111/hsc.12643
  10. 10. Bauchner H. Trust in Health Care. JAMA. 2019; 321(6): 547.10.1001/jama.2018.2079530676627
  11. 11. Johnson SB, Park HS, Gross CP, et al. Complementary Medicine, Refusal of Conventional Cancer Therapy, and Survival among Patients with Curable Cancers. JAMA Oncol. 2018; 4(10):1375-1381.10.1001/jamaoncol.2018.2487623377330027204
  12. 12. Johnson SB, Park HS, Gross CP, et al. Use of Alternative Medicine for Cancer and Its Impact on Survival. JNCI J Natl Cancer Inst. 2018; 110(1): 121-124.10.1093/jnci/djx14528922780
  13. 13. WHO traditional medicine strategy: 2014-2023. Accessed September 9, 2021. https://www.who.int/publications/i/item/9789241506096
  14. 14. Wiesener S, Salamonsen A, Fønnebø V. Which risk understandings can be derived from the current disharmonized regulation of complementary and alternative medicine in Europe? BMC Complement Altern Med. 2018; 18(1): 1-7.10.1186/s12906-017-2073-9576361329321023
  15. 15. Alsanad SM, Howard RL, Williamson EM. An assessment of the impact of herb-drug combinations used by cancer patients. BMC Complement Altern Med. 2016; 16(1): 1-9.10.1186/s12906-016-1372-x507009027756298
  16. 16. Fischer F, Lewith G, Witt CM, et al. a Research Roadmap for Complementary and Alternative Medicine - What We Need to Know by 2020. Complement Med. Res. 2014; 21(2): e1-e16.10.1159/00036074424851850
  17. 17. Xu LP, Yang SL, Su SQ, et al. Effect of wrist-ankle acupuncture therapy combined with auricular acupuncture on cancer pain: a four-parallel arm randomized controlled trial. Complement Ther. Clin. Pract. 2020; 39: 101170.10.1016/j.ctcp.2020.101170
  18. 18. Kok ET, Jong MC, Gravendeel B, et al. Resistance to Antibiotics and Antifungal Medicinal Products: Can Complementary and Alternative Medicine Help Solve the Problem in Common Infection Diseases? The Introduction of a Dutch Research Consortium. Evid Based Complement Alternat Med. 2015; 2015: 1-6.10.1155/2015/521584461990626539227
  19. 19. Eardley S, Bishop FL, Prescott P, et al. a Systematic Literature Review of Complementary and Alternative Medicine Prevalence in EU. Complement Med. Res. 2012; 19(2): 18-28.10.1159/000342708
  20. 20. Jędrzejewska A, Ślusarska BJ, Szadowska-Szlachetka Z, et al. Use of complementary and alternative medicine in patients with cancer and their relationship with health behaviours – Cross-sectional study. Annals Agric. Environ. Med. 2021; 28(3): 475-482.10.26444/aaem/140165
  21. 21. Buckner CA, Lafrenie RM, Dénommée JA, et al. Complementary and alternative medicine use in patients before and after a cancer diagnosis. Curr. Oncol. 2018; 25(4): e275-e281.10.3747/co.25.3884609204930111972
  22. 22. Abuelgasim KA, Alsharhan Y, Alenzi T, et al. The use of complementary and alternative medicine by patients with cancer: Af cross-sectional survey in Saudi Arabia. BMC Complement Altern Med. 2018; 18(1): 88.10.1186/s12906-018-2150-8584853629530034
  23. 23. Edwards GV, Aherne NJ, Horsley PJ, et al. Prevalence of complementary and alternative therapy use by cancer patients undergoing radiation therapy. Asia Pac. J. Clin. Oncol. 2014; 10(4): 346-353.10.1111/ajco.12203
  24. 24. Al-Naggar RA, Bobryshev YV, Abdulghani M, et al. Complementary/alternative medicine use among cancer patients in Malaysia. World J. Med. Sci. 2013; 8(2): 157-164.
  25. 25. Dhanoa A, Yong TL, Yeap SJL, et al. Complementary and alternative medicine use amongst Malaysian orthopaedic oncology patients. BMC Complement Altern Med. 2014; 14(1): 404.10.1186/1472-6882-14-404420902825324121
  26. 26. Oyunchimeg B, Hwang JH, Ahmed M, et al. Complementary and alternative medicine use among patients with cancer in Mongolia: a National hospital survey. BMC Complement Altern Med. 2017; 17(1): 1-8.10.1186/s12906-017-1576-8524457628103860
  27. 27. Demir BD, Erol O. Complementary and Alternative Medicine Use among Turkish Cancer Patients and the Influencing Factors. Int. J. of Caring Sciences. 2018; 11(1): 319-332.
  28. 28. Dogu GG, Kargi A, Tanriverdi O, et al. Complementary/Alternative Medicine Experience in Cancer Patients: a Questionnaire-Based Survey. Int. J. Hematol. Oncol. Artic. 2014; 21(1): 45-53.10.4999/uhod.12008
  29. 29. Üstündağ S, Demir Zencirci A. Complementary and Alternative Medicine Use Among Cancer Patients and Determination of Affecting Factors: a Questionnaire Study. Holist. Nurs. Pract. 2015; 29(6): 357-369.10.1097/HNP.0000000000000113
  30. 30. Jermini M, Dubois J, Rodondi PY. Complementary medicine use during cancer treatment and potential herb-drug interactions from a cross-sectional study in an academic centre. Sci. Rep. 2019; 9 (5078): 1-11.10.1038/s41598-019-41532-3
  31. 31. Davis EL, Oh B, Butow PN, et al. Cancer Patient Disclosure and Patient-Doctor Communication of Complementary and Alternative Medicine Use: a Systematic Review. Oncologist. 2012; 17(11): 1475.10.1634/theoncologist.2012-0223350037022933591
  32. 32. Chang KH, Brodie R, Choong MA, et al. Complementary and alternative medicine use in oncology: a questionnaire survey of patients and health care professionals. BMC Cancer. 2011; 11(1): 196.10.1186/1471-2407-11-196312332421609461
  33. 33. Stan DL, Wahner-Roedler DL, Yost KJ, et al. Absent and Discordant Electronic Health Record Documentation of Complementary and Alternative Medicine in Cancer Care. J. Altern Complement Med. 2018; 24(9-10): 988-995.10.1089/acm.2018.0141615734730247970
  34. 34. Horneber M, Bueschel G, Dennert G, et al. How many cancer patients use complementary and alternative medicine: a systematic review and metaanalysis. Integr. Cancer Ther. 2012; 11(3): 187-203.10.1177/1534735411423920
  35. 35. Broom A, Wijewardena K, Sibbritt D, et al The use of traditional, complementary and alternative medicine in Sri Lankan cancer care: Results from a survey of 500 cancer patients. Public Health. 2010; 124(4): 232-237.10.1016/j.puhe.2010.02.01220363486
  36. 36. Aliyu UM, Awosan KJ, Oche MO, et al. Prevalence and correlates of complementary and alternative medicine use among cancer patients in Usmanu Danfodiyo university teaching hospital, Sokoto, Nigeria. Niger J. Clin. Pract. 2017; 20(12): 1576-1583.10.4103/njcp.njcp_88_17
  37. 37. Liao Y-H, Li C-I, Lin C-C, et al. Traditional Chinese medicine as adjunctive therapy improves the long-term survival of lung cancer patients. J. Cancer Res. Clin. Oncol. 2017; 143(12): 2425-2435.10.1007/s00432-017-2491-6
  38. 38. Gannotta R, Malik S, Chan AY, et al. Integrative Medicine as a Vital Component of Patient Care. Cureus. 2018; 10(8): e3098.10.7759/cureus.3098617327330338174
  39. 39. Maizes V, Rakel D, Niemiec C. Integrative Medicine and Patient-Centered Care. EXPLORE. 2009; 5(5): 277-289.10.1016/j.explore.2009.06.00819733814
  40. 40. Greenlee H, Balneaves LG, Carlson LE, et al. Clinical Practice Guidelines on the Use of Integrative Therapies as Supportive Care in Patients Treated for Breast Cancer. JNCI Monogr. 2014; 2014(50): 346-358.10.1093/jncimonographs/lgu041441153925749602
  41. 41. New EU4Health Programme. Accessed September 9, 2021. https://ec.europa.eu/commission/presscorner/detail/en/qanda_20_956.
  42. 42. Raposo VL. Complementary and alternative medicine, medical liability and the proper standard of care. Complement Ther. Clin. Pract. 2019; 35: 183-188.10.1016/j.ctcp.2019.02.00931003656
DOI: https://doi.org/10.2478/pielxxiw-2022-0014 | Journal eISSN: 2450-646X | Journal ISSN: 1730-1912
Language: English
Page range: 122 - 132
Submitted on: Oct 6, 2021
|
Accepted on: Oct 28, 2021
|
Published on: Jun 24, 2022
Published by: Sciendo
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2022 Aneta Brygida Jędrzejewska, Barbara Janina Ślusarska, Grzegorz Józef Nowicki, published by Sciendo
This work is licensed under the Creative Commons Attribution 4.0 License.